How to Build Reinsurer Confidence in Digital Underwriting

Reinsurer confidence in digital underwriting does not come from a pitch deck. It comes from data. Mortality experience data, to be specific—the kind that shows a carrier's accelerated or instant-issue program produces outcomes comparable to traditional fluid-verified underwriting. Gen Re's 2025 U.S. Individual Life Next Gen Underwriting Survey found that 59% of individual life applications now qualify for an accelerated underwriting path. That is a lot of new business flowing through digital channels. The carriers getting the best treaty terms? They treat reinsurer confidence like an engineering problem, not a sales pitch.

Gen Re's Next Gen Analytics study, with mortality data stretching back to 2019 and covering over 14,000 policies, found that mortality slippage in accelerated underwriting programs stabilized at 12.3% in 2025—a number that gives reinsurers something concrete to price against.

Why Reinsurer Confidence Matters More Now Than Five Years Ago

Five years ago, a carrier could launch an accelerated underwriting pilot and the reinsurer would price it conservatively, shrug, and wait. That tolerance is gone. Accelerated underwriting is no longer experimental—it is the dominant workflow at most carriers. Gen Re reports that the top workflow goals for accelerated underwriting now include reducing time to issue (52%), managing mortality slippage (45%), and increasing sales (41%). Carriers are optimizing, not experimenting. Reinsurers have noticed.

A carrier that cannot show data quality and mortality discipline gets hit with wider mortality loads in treaty pricing, lower face amount limits for accelerated paths, or mandatory post-issue audit requirements that pile on operational cost. On the flip side, carriers bringing transparent, well-governed programs to the table are starting to see real treaty differentiation.

Munich Re's Biometric Portfolio Analysis platform draws on more than 15 years of experience data from over 30 participating insurers. Reinsurers use it to check whether a carrier's digital underwriting model is producing mortality outcomes within expected ranges. Participating in that kind of data-sharing framework tells reinsurers something about how seriously a carrier takes mortality accountability.

The Four Pillars of Reinsurer Confidence

Reinsurers evaluate digital underwriting programs across four dimensions. Nail all four and you negotiate from strength. Miss one and you accept conservative pricing with tight restrictions.

1. Data Source Transparency

Reinsurers want to know exactly which data sources feed the underwriting decision and how much confidence each source warrants. Prescription database checks through services like Milliman IntelliScript are considered standard—reinsurers have years of experience pricing against Rx data. Electronic health records add clinical depth but have incomplete population coverage. Credit-based insurance scores provide behavioral signals but face growing regulatory scrutiny.

The newest layer—objective biometric signals from remote photoplethysmography (rPPG) and wearable devices—is where reinsurer interest is sharpest. These capture real-time physiological data rather than inferring risk from behavioral proxies. Swiss Re's predictive underwriting research has found that AI-driven risk segmentation can target post-issue sampling more accurately, tightening the feedback loop between underwriting decisions and mortality outcomes.

2. Model Governance and Documentation

Reinsurers are not asking whether you use predictive models. They already assume you do. What they want to see is how those models get built, validated, monitored, and updated. Version-controlled documentation, back-testing against historical mortality, and performance monitoring dashboards that someone actually looks at.

The NAIC's Accelerated Underwriting Working Group published regulatory guidance in 2024 addressing model transparency and the impact of algorithmic underwriting on minority populations. Carriers that build governance frameworks aligned with this guidance position themselves well with reinsurers, because reinsurers face their own regulatory scrutiny on the business they accept.

3. Escalation and Override Rates

The percentage of applications that receive fully automated approval versus those escalated to a human underwriter is a variable reinsurers price against directly. Gen Re's 2025 survey data shows that only about 20% of accelerated-eligible applications receive fully automated approval, with 36% approved after human review within the accelerated workflow. Reinsurers generally assign more favorable pricing to programs with conservative automation thresholds.

The tension is obvious: carriers want to automate more to cut costs and cycle time, while reinsurers want to see that approvals are not getting rubber-stamped. The resolution comes down to proving your escalation rules are calibrated to risk, not volume targets.

4. Post-Issue Audit Programs

Post-issue audits close the confidence loop. You randomly sample approved policies and verify underwriting decisions through APS ordering, prescription verification, or biometric re-measurement. Without audits, a reinsurer has to trust model outputs with no independent check. With them, both parties can see actual-versus-expected results and recalibrate.

Swiss Re's underwriting audit services go beyond simple case-checks, covering all aspects of the case-handling process. Carriers that invest in robust post-issue sampling programs and share the results openly with reinsurers build the kind of track record that translates directly into treaty pricing advantages.

Confidence-Building Strategies Compared

Strategy	What It Proves to Reinsurers	Implementation Effort	Treaty Pricing Impact
Mortality experience sharing	Actual vs. expected outcomes from digital cohorts	High—requires 3-5 years of data	Strongest impact; directly reduces mortality loads
Post-issue audit program	Independent verification of underwriting quality	Medium—operational overhead for sampling	Moderate; demonstrates governance commitment
Model governance documentation	Algorithmic transparency and regulatory alignment	Medium—documentation and monitoring infrastructure	Moderate; builds process confidence
Biometric data integration	Objective physiological data supplements behavioral proxies	Medium—technology integration	Growing impact; reinsurers increasingly differentiate
Data source benchmarking	Participation in industry studies (e.g., Munich Re BPA)	Low—data sharing agreement	Moderate; signals industry collaboration
Regulatory alignment	Proactive compliance with NAIC guidance	Low-Medium—policy and process updates	Indirect; reduces reinsurer regulatory concern

Practical Steps Carriers Are Taking

Building a Mortality Evidence Package

The carriers earning the best terms are not waiting around for reinsurers to request mortality data. They show up with what amounts to a mortality evidence package already assembled: actual-versus-expected mortality results segmented by underwriting path, face amount band, age cohort, and data sources used.

Gen Re's Next Gen Analytics study provides a useful template. By tracking mortality slippage—defined as the difference in mortality between policies that would have received the same underwriting decision through traditional and accelerated paths—carriers can quantify the impact of removing fluid verification from specific cohorts. The 2025 finding that slippage stabilized at 12.3% gives carriers a benchmark to present against.

Investing in Biometric Data Quality

Reinsurers have always priced against the absence of fluid data. The question now is whether alternative biometric measurements can partially fill that gap. Remote photoplethysmography captures heart rate, respiratory rate, and blood oxygen signals through a smartphone camera—real physiological data fed back into the underwriting decision without requiring anyone to visit a lab.

Carriers integrating this type of biometric data are positioning themselves to negotiate what some reinsurers call "biometric offset" pricing—reduced adverse selection loads that reflect the presence of objective physiological signals in the underwriting evidence base. Solutions like Circadify are developing camera-based vitals capture specifically designed for insurance underwriting workflows.

Creating Reinsurer-Facing Dashboards

A few carriers have started providing reinsurers with real-time or near-real-time dashboards showing underwriting program performance: application volumes by path, automation rates, escalation triggers, and early mortality indicators. This level of transparency is unusual in the ceding carrier-reinsurer relationship, but the carriers doing it report that it meaningfully changes the tenor of treaty negotiations.

Current Research and Evidence

The evidence base for digital underwriting mortality is still building, but several data points stand out.

Gen Re's Next Gen Underwriting Survey, now in its latest edition, remains the most comprehensive public dataset on accelerated underwriting adoption and outcomes. The 2025 survey documented that top carrier goals for accelerated underwriting have shifted from "launch the program" to "optimize the program"—specifically, reducing time to issue and managing mortality slippage.

Munich Re's Biometric Portfolio Analysis, drawing on over 15 years of cross-carrier data, provides the industry's largest benchmarking dataset for evaluating digital underwriting model performance. Carriers participating in this program gain access to comparative analytics that inform both their own model calibration and their reinsurer negotiations.

The NAIC's Accelerated Underwriting Working Group's 2024 regulatory guidance package addressed model transparency, consumer impact, and the treatment of algorithmic underwriting within existing insurance regulatory frameworks. This guidance is shaping how both carriers and reinsurers approach digital underwriting governance.

Swiss Re's research on AI in predictive underwriting has documented how risk segmentation algorithms can improve post-issue audit targeting, creating tighter feedback loops between underwriting decisions and observed outcomes.

The Future of Reinsurer Confidence in Digital Underwriting

The next three to five years will probably split the market in two. Carriers with solid data governance, transparent mortality evidence, and real biometric data integration will earn treaty terms approaching traditional underwriting pricing. Carriers without those capabilities will watch the price gap widen.

The volume of accelerated underwriting experience data keeps growing, which means mortality credibility studies will have bigger sample sizes and more statistical power. Biometric data sources are expanding past prescription databases and health records into real-time physiological signals. Regulatory frameworks from bodies like the NAIC are setting governance expectations that reinsurers will start treating as baseline requirements, not differentiators.

The carriers getting ahead are treating reinsurer confidence as an ongoing engineering discipline, not something they think about once a year when treaty negotiations come around.

Frequently Asked Questions

What is the biggest factor in building reinsurer confidence?

Mortality experience data. Reinsurers are actuarial organizations, and the most persuasive evidence is actual-versus-expected mortality results from digitally underwritten cohorts. Gen Re's mortality slippage studies provide the benchmark framework that carriers can use to structure their own evidence packages.

How long does it take to build credible mortality data for reinsurers?

Most reinsurers want to see at least three to five years of experience data before granting meaningful pricing credit. Gen Re's Next Gen Analytics study, which tracks data back to 2019, illustrates the timeline needed for credible slippage analysis. Carriers launching new programs should plan for a conservative treaty pricing period during the data accumulation phase.

Do biometric data sources like rPPG help with reinsurer negotiations?

Increasingly, yes. Reinsurers recognize that objective physiological data can partially offset the confidence gap created by removing fluid verification. The impact on treaty pricing is still emerging, but carriers with biometric data in their underwriting evidence base are reporting more constructive reinsurer conversations about adverse selection loads and face amount limits.

What role do post-issue audits play in reinsurer confidence?

Post-issue audits are the verification mechanism that turns model-based underwriting into evidence-based underwriting. By randomly sampling approved policies and independently verifying the underwriting decision, carriers demonstrate to reinsurers that their digital programs produce reliable outcomes—not just outputs.

For more on how reinsurers evaluate digital underwriting pricing, see our analysis of how reinsurers price digitally underwritten life policies.